BACKGROUND: Anti-Mullerian hormone ( @entity248 ) is constantly secreted during menstrual cycles and may offer several advantages over traditional biomarkers of ovarian reserve. OBJECTIVE: To assess the relationship of anti-Mullerian hormone ( @entity248 ) values, which are used to evaluate ovary reserves, with oocyte and embryo quality and with ART outcomes in @entity1 undergoing intra-cytoplasmic sperm injection (ICSI). MATERIALS AND METHODS: This cross sectional study was performed using 50 @entity1 undergoing ICSI in IVF center of Zeynep Kamil @entity1 's and @entity1 's Hospital,   stanbul, @entity233 . All @entity1 received the long protocol. Follicle-stimulating hormone, luteinizing hormone, @entity53 , and @entity248 levels were measured and antral follicle counts were obtained on the 3(rd) day of menstruation. A cut-off value based on the number of oocytes was determined for @entity248 , and @entity1 were evaluated after being divided into two groups as bad responders and good responders, according to their @entity248 levels. RESULTS: Twelve (27.3%) @entity1 were in bad responders group and 32 (72.7%) @entity1 were in good responders group. @entity248 measurements were statistically significantly different between the two groups (p<0.01). Based on this significance, the researchers used ROC analysis to estimate a cut-off point for @entity248 . The researchers detected the good responders with an @entity248 level 1.90 or above, with 87.50% sensitivity, 66.67% specificity, 87.50% positive prediction, and 66.67% negative prediction (AUC=0.777, p<0.01). CONCLUSION: Basal @entity248 levels can be used as an indicator to determine the ovarian response in @entity1 undergoing ICSI. @entity248 can be used to predict the number of mature oocytes that can be collected during treatment and the number of oocytes that can be fertilized. However, @entity248 is not a valuable tool to evaluate oocyte quality, the development of high-quality embryos, or pregnancy conception.

Assessment of the relationship of basal serum anti-mullerian hormone levels with oocyte quality and pregnancy outcomes in XXXX undergoing ICSI.

@entity1 :: ('9606', 'Species') :: ['women', 'patients', 'Children', 'Women'] @entity248 :: ('268', 'Gene') :: ['AMH'] @entity233 :: ('9103', 'Species') :: ['Turkey'] @entity53 :: ('MESH:D004958', 'Chemical') :: ['estradiol']
@entity1 :: (9606,Species) :: ['patients']
